Construction of Recombinant Hemagglutinin Derived from the Gingipain-Encoding Gene of <i>Porphyromonas gingivalis</i> , Identification of Its Target Protein on Erythrocytes, and Inhibition of Hemagglutination by an Interdomain Regional Peptide

  • Eiko Sakai
    Division of Oral Pathopharmacology, Department of Developmental and Reconstructive Medicine
  • Mariko Naito
    Division of Microbiology and Oral Infection, Department of Molecular Microbiology and Immunology
  • Keiko Sato
    Division of Microbiology and Oral Infection, Department of Molecular Microbiology and Immunology
  • Hitoshi Hotokezaka
    Division of Orthodontics and Dentofacial Orthopedics, Department of Developmental and Reconstructive Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
  • Tomoko Kadowaki
    Department of Pharmacology, Graduate School of Dental Science, Kyushu University, Fukuoka, Japan
  • Arihide Kamaguchi
    Department of Oral Microbiology, School of Dentistry, Health Sciences University of Hokkaido, Sapporo, Japan
  • Kenji Yamamoto
    Department of Pharmacology, Graduate School of Dental Science, Kyushu University, Fukuoka, Japan
  • Kuniaki Okamoto
    Division of Oral Pathopharmacology, Department of Developmental and Reconstructive Medicine
  • Koji Nakayama
    Division of Microbiology and Oral Infection, Department of Molecular Microbiology and Immunology

抄録

<jats:title>ABSTRACT</jats:title> <jats:p> <jats:italic>Porphyromonas gingivalis</jats:italic> , an anaerobic gram-negative bacterium associated with chronic periodontitis, can agglutinate human erythrocytes. In general, hemagglutination can be considered the ability to adhere to host cells; however, <jats:italic>P. gingivalis</jats:italic> -mediated hemagglutination has special significance because heme markedly accelerates growth of this bacterium. Although a number of studies have indicated that a major hemagglutinin of <jats:italic>P. gingivalis</jats:italic> is intragenically encoded by <jats:italic>rgpA</jats:italic> , <jats:italic>kgp</jats:italic> , and <jats:italic>hagA</jats:italic> , direct evidence has not been obtained. We demonstrated in this study that recombinant HGP44 <jats:sub>720-1081</jats:sub> , a fully processed HGP44 domain protein, had hemagglutinating activity but that an unprocessed form, HGP44 <jats:sub>720-1138</jats:sub> , did not. A peptide corresponding to residues 1083 to 1102, which was included in HGP44 <jats:sub>720-1138</jats:sub> but not in HGP44 <jats:sub>720-1081</jats:sub> , could bind HGP44 <jats:sub>720-1081</jats:sub> in a dose-dependent manner and effectively inhibited HGP44 <jats:sub>720-1081</jats:sub> -mediated hemagglutination, indicating that the interdomain regional amino acid sequence may function as an intramolecular suppressor of hemagglutinating activity. Analyses by solid-phase binding and chemical cross-linking suggested that HGP44 interacted with glycophorin A on the erythrocyte membrane. Glycophorin A and, more effectively, asialoglycophorin, which were added exogenously, inhibited HGP44 <jats:sub>720-1081</jats:sub> -mediated hemagglutination. Treatment of erythrocytes with RgpB proteinase resulted in degradation of glycophorin A on the membrane and a decrease in HGP44 <jats:sub>720-1081</jats:sub> -mediated hemagglutination. Surface plasmon resonance detection analysis revealed that HGP44 <jats:sub>720-1081</jats:sub> could bind to asialoglycophorin with a dissociation constant of 3.0 × 10 <jats:sup>−7</jats:sup> M. These results indicate that the target of HGP44 on the erythrocyte membrane appears to be glycophorin A. </jats:p>

収録刊行物

被引用文献 (9)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ